Cargando…

A global agenda for older adult immunization in the COVID-19 era: A roadmap for action

Given our global interconnectedness, the COVID-19 pandemic highlights the urgency of building a global system that can support both routine and pandemic/epidemic adult immunization. As such, a framework to recommend vaccines and build robust platforms to deliver them to protect the rapidly expanding...

Descripción completa

Detalles Bibliográficos
Autores principales: Privor-Dumm, Lois A., Poland, Gregory A., Barratt, Jane, Durrheim, David N., Deloria Knoll, Maria, Vasudevan, Prarthana, Jit, Mark, Bonvehí, Pablo E., Bonanni, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332930/
https://www.ncbi.nlm.nih.gov/pubmed/32703743
http://dx.doi.org/10.1016/j.vaccine.2020.06.082
_version_ 1783553635675799552
author Privor-Dumm, Lois A.
Poland, Gregory A.
Barratt, Jane
Durrheim, David N.
Deloria Knoll, Maria
Vasudevan, Prarthana
Jit, Mark
Bonvehí, Pablo E.
Bonanni, Paolo
author_facet Privor-Dumm, Lois A.
Poland, Gregory A.
Barratt, Jane
Durrheim, David N.
Deloria Knoll, Maria
Vasudevan, Prarthana
Jit, Mark
Bonvehí, Pablo E.
Bonanni, Paolo
author_sort Privor-Dumm, Lois A.
collection PubMed
description Given our global interconnectedness, the COVID-19 pandemic highlights the urgency of building a global system that can support both routine and pandemic/epidemic adult immunization. As such, a framework to recommend vaccines and build robust platforms to deliver them to protect the rapidly expanding demographic of older adults is needed. Adult immunization as a strategy has the broad potential to preserve and improve medical, social, and economic outcomes, including maintaining functional ability that benefits older adults, their families, communities, and countries. While we will soon have multiple vaccines against COVID-19, we must recognize that we already have a variety of vaccines against other pathogens that can keep adults healthier. They can prevent simultaneous co-infection with COVID-19, and may favorably impact- the outcome of a COVID-19 illness. Further, administering a vaccine against COVID-19 requires planning now to determine delivery strategies impacting how older adults will be immunized in a timely manner. A group of international experts with various backgrounds from health and aging disciplines met to discuss the evidence case for adult immunization and crucial knowledge gaps that must be filled in order to implement effective policies and programs for older adult immunization. This group, coming together as the International Council on Adult Immunization (ICAI), outlined a high-level roadmap to catalyze action, provide policy guidance, and envision a global adult immunization platform that can be adapted by countries to fit their local contexts. Further meetings centered around the value of adult immunization, particularly in the context of COVID-19. There was agreement that programs to deliver existing influenza, pneumococcal, herpes zoster vaccines, and future COVID-19 vaccines to over a billion older adults who are at substantially higher risk of death and disability due to vaccine-preventable diseases are more urgent than ever before. Here we present a proposed framework for delivering routine and pandemic vaccines. We call upon the global community and governments to prioritize action for integrating robust adult immunization programs into the public health agenda.
format Online
Article
Text
id pubmed-7332930
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-73329302020-07-06 A global agenda for older adult immunization in the COVID-19 era: A roadmap for action Privor-Dumm, Lois A. Poland, Gregory A. Barratt, Jane Durrheim, David N. Deloria Knoll, Maria Vasudevan, Prarthana Jit, Mark Bonvehí, Pablo E. Bonanni, Paolo Vaccine Conference Report Given our global interconnectedness, the COVID-19 pandemic highlights the urgency of building a global system that can support both routine and pandemic/epidemic adult immunization. As such, a framework to recommend vaccines and build robust platforms to deliver them to protect the rapidly expanding demographic of older adults is needed. Adult immunization as a strategy has the broad potential to preserve and improve medical, social, and economic outcomes, including maintaining functional ability that benefits older adults, their families, communities, and countries. While we will soon have multiple vaccines against COVID-19, we must recognize that we already have a variety of vaccines against other pathogens that can keep adults healthier. They can prevent simultaneous co-infection with COVID-19, and may favorably impact- the outcome of a COVID-19 illness. Further, administering a vaccine against COVID-19 requires planning now to determine delivery strategies impacting how older adults will be immunized in a timely manner. A group of international experts with various backgrounds from health and aging disciplines met to discuss the evidence case for adult immunization and crucial knowledge gaps that must be filled in order to implement effective policies and programs for older adult immunization. This group, coming together as the International Council on Adult Immunization (ICAI), outlined a high-level roadmap to catalyze action, provide policy guidance, and envision a global adult immunization platform that can be adapted by countries to fit their local contexts. Further meetings centered around the value of adult immunization, particularly in the context of COVID-19. There was agreement that programs to deliver existing influenza, pneumococcal, herpes zoster vaccines, and future COVID-19 vaccines to over a billion older adults who are at substantially higher risk of death and disability due to vaccine-preventable diseases are more urgent than ever before. Here we present a proposed framework for delivering routine and pandemic vaccines. We call upon the global community and governments to prioritize action for integrating robust adult immunization programs into the public health agenda. Elsevier Science 2021-08-31 2020-07-03 /pmc/articles/PMC7332930/ /pubmed/32703743 http://dx.doi.org/10.1016/j.vaccine.2020.06.082 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Conference Report
Privor-Dumm, Lois A.
Poland, Gregory A.
Barratt, Jane
Durrheim, David N.
Deloria Knoll, Maria
Vasudevan, Prarthana
Jit, Mark
Bonvehí, Pablo E.
Bonanni, Paolo
A global agenda for older adult immunization in the COVID-19 era: A roadmap for action
title A global agenda for older adult immunization in the COVID-19 era: A roadmap for action
title_full A global agenda for older adult immunization in the COVID-19 era: A roadmap for action
title_fullStr A global agenda for older adult immunization in the COVID-19 era: A roadmap for action
title_full_unstemmed A global agenda for older adult immunization in the COVID-19 era: A roadmap for action
title_short A global agenda for older adult immunization in the COVID-19 era: A roadmap for action
title_sort global agenda for older adult immunization in the covid-19 era: a roadmap for action
topic Conference Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332930/
https://www.ncbi.nlm.nih.gov/pubmed/32703743
http://dx.doi.org/10.1016/j.vaccine.2020.06.082
work_keys_str_mv AT privordummloisa aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT polandgregorya aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT barrattjane aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT durrheimdavidn aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT deloriaknollmaria aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT vasudevanprarthana aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT jitmark aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT bonvehipabloe aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT bonannipaolo aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT privordummloisa globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT polandgregorya globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT barrattjane globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT durrheimdavidn globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT deloriaknollmaria globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT vasudevanprarthana globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT jitmark globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT bonvehipabloe globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT bonannipaolo globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction
AT globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction